Insmed (INSM) Interest & Investment Income (2010 - 2026)

Insmed's (INSM) quarterly Interest & Investment Income came in at $12.0 million in Q1 2026, down 13.42% year-on-year from $13.9 million in Q1 2025, and down 20.98% quarter-over-quarter from $15.2 million in Q4 2025.

Insmed (INSM) Interest & Investment Income (2010 - 2026) Analysis & Trends

Insmed's Interest & Investment Income history runs 17 years deep, the most recent figure standing at $12.0 million for Q1 2026.

  • On a quarterly basis, Interest & Investment Income fell 13.42% year-over-year to $12.0 million in Q1 2026; TTM through Mar 2026 was $58.8 million, a 0.62% increase from a year earlier, with the FY2025 full-year figure at $60.7 million, up 13.79% from the prior year.
  • Interest & Investment Income retreated to $12.0 million in Q1 2026 per INSM's latest filing, from $15.2 million in the prior quarter.
  • Across five years, Interest & Investment Income topped out at $18.3 million in Q3 2025 and bottomed at $137000.0 in Q1 2022.
  • The 5-year median for Interest & Investment Income is $10.6 million (2023), against an average of $10.5 million.
  • Across the five-year window, Interest & Investment Income surged 13536.07% in 2022 and slipped 16.54% in 2024, its largest moves.
  • Year by year, Interest & Investment Income stood at $8.3 million in 2022, then gained by 18.45% to $9.9 million in 2023, then surged by 75.14% to $17.3 million in 2024, then decreased by 11.71% to $15.2 million in 2025, then slipped by 20.98% to $12.0 million in 2026.
  • Per Business Quant, the three latest INSM Interest & Investment Income figures stand at $12.0 million (Q1 2026), $15.2 million (Q4 2025), and $18.3 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int & Inv Inc (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn - -
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn 27.66 Mn
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn 114.80 Mn
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn -65.80 Mn
7 Belite Bio 62.72 Bn 62.72 Bn - -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn 48.00 Mn
9 Revolution Medicines 37.35 Bn 37.35 Bn - 19.51 Mn
10 Insmed 22.60 Bn 21.38 Bn 258.54 Mn 12.04 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 12.04 Mn
Dec 31, 2025 15.24 Mn
Sep 30, 2025 18.29 Mn
Jun 30, 2025 13.23 Mn
Mar 31, 2025 13.91 Mn
Dec 31, 2024 17.26 Mn
Sep 30, 2024 16.98 Mn
Jun 30, 2024 10.29 Mn
Mar 31, 2024 8.78 Mn
Dec 31, 2023 9.85 Mn
Sep 30, 2023 10.58 Mn
Jun 30, 2023 11.17 Mn
Mar 31, 2023 10.52 Mn
Dec 31, 2022 8.32 Mn
Sep 30, 2022 1.79 Mn
Jun 30, 2022 835,000.00
Mar 31, 2022 137,000.00
Dec 31, 2021 61,000.00
Sep 30, 2021 46,000.00
Jun 30, 2021 34,000.00